High-Dose Selenium IV Alleviates Chemotherapy-Induced Neuropathy in Ovarian Cancer Patients
High-dose intravenous selenium may significantly reduce chemotherapy-induced peripheral neuropathy (CIPN)—characterized by numbness and gait instability—in ovarian cancer patients. Recent evidence suggests this antioxidant intervention mitigates oxidative nerve damage, potentially improving ... Read More